Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Dec 09 • 04:00PM ET

46.36

-0.41 -0.88 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI WCMI PID RVER AQEC APIE DIVZ

Scroll to Statements

Index	-	P/E	13.50	EPS (ttm)	3.43	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-2.26%
Market Cap	156.17B	Forward P/E	12.94	EPS next Y	3.58	Insider Trans	-	Shs Float	3.37B	Perf Month	1.49%
Enterprise Value	166.97B	PEG	2.01	EPS next Q	0.91	Inst Own	9.03%	Short Float	0.82%	Perf Quarter	-14.73%
Income	15.29B	P/S	3.34	EPS this Y	15.93%	Inst Trans	-1.58%	Short Ratio	1.65	Perf Half Y	-41.56%
Sales	46.69B	P/B	7.70	EPS next Y	-2.22%	ROA	21.83%	Short Interest	27.69M	Perf YTD	-46.11%
Book/sh	6.02	P/C	30.45	EPS next 5Y	6.44%	ROE	68.30%	52W High	112.52 -58.80%	Perf Year	-57.40%
Cash/sh	1.52	P/FCF	15.61	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	43.08 7.61%	Perf 3Y	-26.93%
Dividend Est.	1.77 (3.82%)	EV/EBITDA	7.25	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	1.91% 2.59%	Perf 5Y	36.07%
Dividend TTM	1.73 (3.73%)	EV/Sales	3.58	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	1.53	Perf 10Y	65.01%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	40.04	Recom	2.27
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	-3.37%	Beta	0.67	Target Price	60.30
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	-10.07%	Rel Volume	0.61	Prev Close	46.77
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-25.82%	Avg Volume	16.77M	Price	46.36
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.18% -2.89%	Trades		Volume	10,229,594	Change	-0.88%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral

Show Previous Ratings

Today 04:13PM	In The 'Uber Bull' Biotech Market, Is Structure The Next Metsera? (Investor's Business Daily)
12:30PM	Pfizer Expands Obesity Pipeline With Up to $2.1 Billion Deal for YaoPharma Pill (GuruFocus.com)
11:12AM	Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play (Zacks)
09:27AM	GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron (Zacks)
05:59AM	Pfizer dips into China for another try at an obesity pill (BioPharma Dive)
03:36PM	Loading…
Dec-08-25 03:36PM	Why Novo Nordisk Stock Was Melting on Monday (Motley Fool)
12:46PM	Obesity Biotechs Gains Hit Shares of Eli Lilly, Novo Nordisk (Barrons.com)
10:36AM	Structure Therapeutics Stock Jumps on Trial Results for Weight-Loss Pill (The Wall Street Journal)
Dec-05-25 04:58PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:25PM	Do These 3 Healthcare Stocks Need a Checkup? (Motley Fool)
11:25AM	This Pharmaceutical Giant Fell by 10% After a Setback: Time to Sell the Stock? (Motley Fool)
07:59AM	Wegovy's prices are going down, but they are 'wildly different' (MarketWatch)
Dec-04-25 01:50PM	Denmark's $600 Billion Economy Just Got a Boost--Thanks to One Drugmaker (GuruFocus.com)
01:48PM	Novo Nordisk Stock Rises -- Alzheimer's Program Hints at Potential Gains (GuruFocus.com)
11:42AM	LLY Trading Above 50 & 200-Day SMAs for 2 Months: How to Play the Stock (Zacks)
11:06AM	Loading…
11:06AM	Hims & Hers Stock Gains on Move Into Canada (The Wall Street Journal)
10:29AM	Novo Nordisk A/S (NVO): A Bull Case Theory (Insider Monkey)
10:15AM	The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz (Investor's Business Daily)
08:42AM	Novo Nordisk Leans on India After Trial Miss (GuruFocus.com)
05:41AM	Novo Nordisk gears up for Ozempic launch in India, sources say (Reuters Videos)
Dec-03-25 01:10PM	1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year (Motley Fool)
09:30AM	Medicare Just Cut the Price of Wegovy: Should You Sell Novo Nordisk Stock? (Motley Fool)
09:26AM	Can LLY Strengthen Its Lead as GLP-1 Price Cuts Reshape the Market? (Zacks)
Dec-02-25 12:28PM	LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website (Zacks)
11:23AM	Novo's $1 Billion Obesity Bet Just Took a Shocking Turn--And It Starts With 8-Year-Olds (GuruFocus.com)
09:00AM	Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock (Zacks)
Dec-01-25 12:01PM	Are GLP-1s The New Performance-Enhancing Drug For Careers? (Benzinga)
10:14AM	Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound (Bloomberg)
10:04AM	Eli Lilly cuts cash price for Zepbound weight loss drug vials (Quartz)
09:26AM	VKTX Stock Rises 34% in Three Months: Here's What You Should Know (Zacks)
07:07AM	Loading…
07:07AM	Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know. (Motley Fool)
05:00AM	The weight loss drug boom is just getting started: What's next (Quartz)
Nov-29-25 07:35PM	Why Novo Nordisk Stock Just Hit a 4-Year Low (Motley Fool)
Nov-28-25 04:00PM	Why Eli Lilly's 'market-cap explosion' might be 'misplaced' (Yahoo Finance Video)
Nov-27-25 11:51AM	Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet? (Zacks)
11:24AM	Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of Wegovy (Zacks)
08:15AM	Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 (Motley Fool)
06:43AM	Nordisk Rises After Medicare Slashes GLP-1 Prices (GuruFocus.com)
05:51AM	J.P. Morgan Reiterates a Buy Rating on ?Novo Nordisk (NVO) (Insider Monkey)
Nov-26-25 04:11PM	Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied (Investor's Business Daily)
02:48PM	Why Novo Nordisk Stock Is Moving Higher Today (Motley Fool)
12:33PM	Health Care Roundup: Market Talk (The Wall Street Journal)
10:55AM	Drug prices: RJ says Trumps first try more aggressive than Bidens (Investing.com)
10:45AM	NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes (Zacks)
10:42AM	AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights (Zacks)
09:06AM	Layoffs are piling up, raising worker anxiety. Here are some companies that have cut jobs recently (Associated Press Finance)
08:42AM	Novo Nordisk Seeks FDA Approval For Higher Dose of Wegovy Weight-Loss Shot (The Wall Street Journal)
08:33AM	Price cut for obesity drugs, HP job cuts, Tesla's robotaxi expansion (Yahoo Finance Video)
07:52AM	Novo Nordisk to advance amylin agonist to Phase III in type 2 diabetes (Clinical Trials Arena)
06:43AM	Stocks to Watch Wednesday: Dell, HP, Workday, Deere (The Wall Street Journal)
06:13AM	Novo Nordisk Faces 71% Medicare Price Cuts on Ozempic and Wegovy (GuruFocus.com)
04:15AM	Did Pfizer Just Say "Checkmate" to Novo Nordisk? (Motley Fool)
Nov-25-25 08:52PM	Trump administration slashes Ozempic and Wegovy price for Medicare (Financial Times)
04:27PM	These Stocks Moved the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohls, Novo Nordisk, Symbotic, and More (Barrons.com)
04:12PM	Should You Buy the Massive Dip in Novo Nordisk Stock? (Barchart)
02:14PM	These Stocks Are Moving the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohls, Novo Nordisk, Symbotic, and More (Barrons.com)
01:37PM	Here's Why Novo Nordisk Stock Popped Today (Motley Fool)
12:58PM	Novo's Comeback Shot? Weight-Loss Drug Triggers Surprise Rally After Brutal Stock Crash (GuruFocus.com)
12:39PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:10AM	NVO Stock Down as Rybelsus Misses Goals in 2 Alzheimer's Studies (Zacks)
09:47AM	Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial (The Wall Street Journal)
09:42AM	Stocks to Watch Tuesday: Alibaba, Alphabet, Novo Nordisk, Kohl's (The Wall Street Journal)
09:08AM	Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better. (Barrons.com)
08:44AM	Novo Nordisk (NVO) is Trending On Reddit - Here's Why (Insider Monkey)
08:07AM	Novo Nordisk's Wegovy Shows Weight Loss-Independent Liver Benefits in MASH Trial Data (Insider Monkey)
08:04AM	Novo Nordisk's weight-loss-drug trial provides rare good news in a rocky year (MarketWatch)
04:22AM	Company News for Nov 25, 2025 (Zacks)
Nov-24-25 06:48PM	Why Novo Nordisk Stock Sank 5.6% Today (Motley Fool) -5.58%
06:42PM	Mizuho's Jared Holz talks Novo Nordisk falling on Alzheimer's trial (CNBC TV)
04:57PM	There's still hope GLP-1 drugs could slow the second-biggest type of dementia (MarketWatch)
04:49PM	Biggest Stock Movers Today, Nov. 24: AVGO, NVO, & More (Motley Fool)
04:33PM	Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps (Investor's Business Daily)
04:23PM	Novo Nordisk has a lot of challenges next year and beyond, says Guggenheim's Seamus Fernandez (CNBC TV)
04:17PM	These Stocks Moved the Most Today: Alphabet, Broadcom, Tesla, Nvidia, Novo Nordisk, Oscar Health, Inspire Medical, and More (Barrons.com)
03:05PM	These Stocks Are Moving the Most Today: Alphabet, Broadcom, Tesla, Nvidia, Novo Nordisk, Oscar Health, Inspire Medical, and More (Barrons.com)
02:50PM	Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's (The Wall Street Journal)
02:23PM	Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman (CNBC TV)
12:58PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
12:40PM	Citi's Geoff Meacham: Novo misses on Alzheimer's trial, but 'winners keep winning' in obesity drugs (CNBC TV)
12:30PM	Moderna is the S&P 500's most shorted stock: Here's why (Yahoo Finance Video)
12:15PM	Novo's GLP-1 fails Alzheimer's trial goals, Tegna stock falls (Yahoo Finance Video)
11:46AM	Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock (GuruFocus.com)
11:35AM	Stock Market Today: Dow, Nasdaq Up As This Stock Tests Entry; Health Plays Pop (Live Coverage) (Investor's Business Daily)
11:34AM	Novo Nordisk Stock Falls. Why Its Alzheimer's Trial News Is Hitting Shares. (Barrons.com)
10:59AM	Novo Nordisk Stock Falls Double Digits -- Ozempic Pill Fails Alzheimer's Test (GuruFocus.com)
10:53AM	Novo Nordisk shares drop after Alzheimer's trial misses main goal (GuruFocus.com)
10:46AM	Failing Drug Stock Suffers Another Blow on Drug Trial Data (Schaeffer's Research)
10:40AM	Novo Nordisks Alzheimers Trials Were a Long Shot. Their Failure Is Still Hitting the Stock. (Barrons.com)
09:36AM	Stocks to Watch Monday: Alibaba, Tesla, Alphabet, Performance Food (The Wall Street Journal)
09:35AM	Elon Musk hypes Tesla AI chips, Novo stock plunges on drug trial flop (Yahoo Finance Video)
09:32AM	Novo Nordisk Stock Price Falls After Ozempic Fails to Slow Alzheimer's (The Wall Street Journal)
09:22AM	Biogen to gain from Novo Nordisk Alzheimers failure, says Jefferies (Investing.com)
08:30AM	Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand? (Zacks)
08:19AM	Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps (Investor's Business Daily)
08:16AM	Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally (Zacks)
08:06AM	Ukraine peace, robotaxis and pharma: what's moving stocks (Yahoo Finance Video)
07:30AM	Novo Nordisk's oral GLP-1 drug didn't work on Alzheimer's as hoped, and the stock tumbles (MarketWatch)
07:25AM	Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's in Trials. Biogen Jumps. (Barrons.com)
07:13AM	Novo Nordisk slumps, Alphabet gains, and other stocks on the move (MarketWatch)
06:59AM	Novo Nordisk shares sink after Alzheimers drug trial failure (Investing.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience